advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (7)
Showing records 1 to 7
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation19258 Ocular hypotensive effect of 1% carteolol long-acting eye drops - a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product
Yamamoto T
Nippon Ganka Gakkai Zasshi 2007; 111: 463-472
19308 Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor
Aggarwal D; Pal D; Mitra AK; Kaur IP
International Journal of Pharmaceutics 2007; 338: 21-26
19601 In Vitro Studies of Antiglaucomatous Prostaglandin Analogues: Travoprost with and without Benzalkonium Chloride and Preserved Latanoprost
Baudouin C; Riancho L; Warnet JM; Brignole F
Investigative Ophthalmology and Visual Science 2007; 48: 4123-4128
19275 Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery
Cao Y; Zhang C; Shen W; Cheng Z; Yu LL; Ping Q
Journal of Controlled Release 2007; 120: 186-194
19607 Coated microneedles for drug delivery to the eye
Jiang J; Gill HS; Ghate D; McCarey BE; Patel SR; Edelhauser HF; Prausnitz MR
Investigative Ophthalmology and Visual Science 2007; 48: 4038-4043
19534 A model for quantifying difficulty in squeezing eyedrops from their containers
Nesher R; Ezra-Nimni O; Shumla E; Gur J; Hamisha S; Nesher G
Archives of Ophthalmology 2007; 125: 1114-1117
19513 Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye
Sigurdsson HH; Konráðsdóttir F; Loftsson T; Stefánsson E
Acta Ophthalmologica Scandinavica 2007; 85: 598-602
